BioSpace News Archive

R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at three upcoming investor conferences:

According to a new survey which aims to shed light on Coloradans understanding and knowledge of their fertility health, 75% of Coloradans admit to feeling “uninformed,” “clueless” or only “somewhat knowledgeable” about their fertility health.

The first clinical study which has been published in the Journal of Applied Microbiology documents that SynForU™-HerCare is effective in reducing vulvovaginal symptoms and recurrences of vaginal candidiasis (VC) in pregnant women.

ETERN Therapeutics, a clinical-stage biotech company focusing on developing novel technologies to target “undruggable” proteins, announced the completion of a Series B financing round.

VectivBio Holding AG, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, announced that it will acquire Comet Therapeutics, Inc., a privately held company that has been developing drugs to address previously untreatable Inherited Metabolic Diseases.

Berkshire Biomedical, LLC announces today that it joins with the millions of advocates around the world in recognition of International Overdose Awareness Day.

iCAD, Inc. today announced that encouraging results from a prospective two center comparative study evaluating the Xoft® Axxent® Electronic Brachytherapy (eBx®) System® for the treatment of recurrent glioblastoma (GBM)

MicroTransponder, Inc. today announced United States Food and Drug Administration (FDA) Premarket Approval of the Vivistim Paired VNS™ System, which significantly improves the effectiveness of rehabilitation therapy for stroke survivors with moderate to severe upper extremity impairment six months after stroke.

Rover Labs, a diagnostics technology leader in end-to-end COVID testing, announced today the launch of Rover CloudLIS, a proprietary, HIPAA-compliant, cloud-based laboratory information system (LIS).

The Janssen Pharmaceutical Companies of Johnson & Johnson announced multiple company-sponsored presentations in prostate and bladder cancers will be highlighted at the virtual 2021 American Urological Association Annual Meeting, September 10-13.